Establishment of reference ranges for ClotPro® in parturients
| Authors | |
|---|---|
| Year of publication | 2025 |
| Type | Article in Periodical |
| Magazine / Source | ANAESTHESIA |
| MU Faculty or unit | |
| Citation | |
| web | https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1111/anae.16776 |
| Doi | https://doi.org/10.1111/anae.16776 |
| Description | Severe haemorrhage remains the leading cause of maternal mortality worldwide. International guidelines recommend the use of viscoelastic testing to guide post-partum haemorrhage (PPH) treatment. Unlike traditional assays, viscoelastic testing uses whole blood and provides real-time clotting data, enabling faster decisions. Viscoelastic testing results correlate with fibrinogen levels and help predict PPH progression and outcomes. Previous studies used older devices like ROTEM® (Werfen, Barcelona, Spain) or TEG® (Haemonetics Corporation, Boston, MA, USA) but not the newer ClotPro® (Haemonetics Corporation). This shares key features with ROTEM yet may yield different results; thus, ClotPro-specific reference ranges are needed. This study aimed to establish corresponding reference ranges in parturients using the ClotPro device. |
| Related projects: |